{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:33:26Z","timestamp":1791084806685,"version":"4.1.0"},"reference-count":89,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/mol.0b013e328354c790","type":"journal-article","created":{"date-parts":[[2012,5,17]],"date-time":"2012-05-17T17:43:04Z","timestamp":1337276584000},"page":"303-309","source":"Crossref","is-referenced-by-count":25,"title":["Postprandial dyslipidaemia and diabetes"],"prefix":"10.1097","volume":"23","author":[{"given":"Jing","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Hugh R.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20211004","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/bmj.316.7134.823","article-title":"Risk factors for coronary artery disease in noninsulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23).","volume":"316","author":"Turner","year":"1998","journal-title":"Br Med J"},{"key":"R2-6-20211004","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/hrt.2010.204990","article-title":"Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient.","volume":"97","author":"Watts","year":"2011","journal-title":"Heart"},{"key":"R3-6-20211004","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3132\/dvdr.2008.046","article-title":"The residual risk reduction initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients.","volume":"5","author":"Fruchart","year":"2008","journal-title":"Diabet Vasc Dis Res"},{"key":"R4-6-20211004","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00125-003-1111-y","article-title":"Diabetic dyslipidaemia: from basic research to clinical practice.","volume":"46","author":"Taskinen","year":"2003","journal-title":"Diabetologia"},{"key":"R5-6-20211004","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosissup.2010.03.003","article-title":"The mechanism of the formation and secretion of chylomicrons.","volume":"11","author":"Kindel","year":"2010","journal-title":"Atheroscler Suppl"},{"key":"R6-6-20211004","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.bbalip.2011.09.019","article-title":"Regulation of chylomicron production in humans.","volume":"1821","author":"Xiao","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"R7-6-20211004","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1161\/CIRCULATIONAHA.107.739888","article-title":"Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans.","volume":"117","author":"Duez","year":"2008","journal-title":"Circulation"},{"key":"R8-6-20211004","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.atherosclerosis.2012.02.001","article-title":"Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.","volume":"222","author":"Adiels","year":"2012","journal-title":"Atherosclerosis"},{"key":"R9-6-20211004","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2337\/db09-1297","article-title":"Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acids.","volume":"59","author":"Pavlic","year":"2010","journal-title":"Diabetes"},{"key":"R10-6-20211004","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/ATVBAHA.111.242073","article-title":"Absence of acute inhibitory effect of insulin on chylomicron production in type 2 diabetes.","volume":"32","author":"Nogueira","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R11-6-20211004","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.atherosclerosis.2008.07.046","article-title":"Insulin stimulates hepatic low density lipoprotein receptor-related protein 1 (LRP1) to increase postprandial lipoprotein clearance.","volume":"204","author":"Laatsch","year":"2009","journal-title":"Atherosclerosis"},{"key":"R12-6-20211004","first-page":"795","article-title":"Adipocytokines and VLDL Metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics D","volume":"54","author":"Ng","year":"2005","journal-title":"iabetes"},{"key":"R13-6-20211004","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.metabol.2009.08.020","article-title":"Type 2 diabetes mellitus is characterized by reduced postprandial adiponectin response: a possible link with diabetic postprandial dyslipidemia.","volume":"59","author":"Annuzzi","year":"2010","journal-title":"Metab Clin Exp"},{"key":"R14-6-20211004","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bbalip.2011.10.007","article-title":"Allelic and phenotypic spectrum of plasma triglycerides.","volume":"1821","author":"Johansen","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"R15-6-20211004","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.atherosclerosissup.2010.03.002","article-title":"Update on genetics of postprandial lipemia.","volume":"11","author":"Perez-Martinez","year":"2010","journal-title":"Atheroscler Suppl"},{"key":"R16-6-20211004","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease.","volume":"302","year":"2009","journal-title":"JAMA"},{"key":"R17-6-20211004","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/138945009787846434","article-title":"Nonfasting hyperlipidemia and cardiovascular disease.","volume":"10","author":"Nordestgaard","year":"2009","journal-title":"Curr Drug Targets"},{"key":"R18-6-20211004","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"key":"R19-6-20211004","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1373\/clinchem.2010.157164","article-title":"Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58434 individuals from the Copenhagen General Population Study.","volume":"57","author":"Langsted","year":"2011","journal-title":"Clin Chem"},{"key":"R20-6-20211004","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00125-010-1945-z","article-title":"Nonfasting lipids and risk of cardiovascular disease in patients with diabetes mellitus.","volume":"54","author":"van Dieren","year":"2011","journal-title":"Diabetologia"},{"key":"R21-6-20211004","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/CIRCULATIONAHA.108.777334","article-title":"Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events.","volume":"118","author":"Mora","year":"2008","journal-title":"Circulation"},{"key":"R22-6-20211004","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1194\/jlr.M900092-JLR200","article-title":"Measures of postprandial lipoproteins are not associated with coronary artery disease in patients with type 2 diabetes mellitus.","volume":"50","author":"Reyes-Soffer","year":"2009","journal-title":"J Lipid Res"},{"key":"R23-6-20211004","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.2337\/dc10-2414","article-title":"Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up.","volume":"34","author":"Cavalot","year":"2011","journal-title":"Diab Care"},{"key":"R24-6-20211004","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2337\/diacare.23.9.1401","article-title":"Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes.","volume":"23","author":"Teno","year":"2000","journal-title":"Diab Care"},{"key":"R25-6-20211004","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1385\/ENDO:28:2:157","article-title":"Association between postprandial remnant-like particle triglyceride (RLP-TG) levels and carotid intima-media thickness (IMT) in Japanese patients with type 2 diabetes.","volume":"28","author":"Mori","year":"2005","journal-title":"Endocrine"},{"key":"R26-6-20211004","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.atherosclerosis.2009.11.015","article-title":"Postchallenge plasma glucose excursions, carotid intima-media thickness, and risk factors for atherosclerosis in Chinese population with type 2 diabetes.","volume":"210","author":"Hu","year":"2010","journal-title":"Atherosclerosis"},{"key":"R27-6-20211004","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cca.2009.12.022","article-title":"Postprandial apolipoprotein B48 is associated with asymptomatic peripheral arterial disease: a study in patients with type 2 diabetes and controls.","volume":"411","author":"Valdivielso","year":"2010","journal-title":"Clinica Chimica Acta"},{"key":"R28-6-20211004","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.atherosclerosissup.2010.04.042","article-title":"Particle size of apoB48 carrying lipoproteins in postprandial plasma.","volume":"11","author":"Nakajima","year":"2010","journal-title":"Atheroscler Suppl"},{"key":"R29-6-20211004","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.cca.2011.04.018","article-title":"Postprandial lipoprotein metabolism; VLDL vs chylomicrons.","volume":"412","author":"Nakajima","year":"2011","journal-title":"Clinica Chimica Acta"},{"key":"R30-6-20211004","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.cca.2012.02.026","article-title":"The characteristics of remnant lipoproteins in the fasting and postprandial plasma.","volume":"413","author":"Nakajima","year":"2012","journal-title":"Clinica Chimica Acta"},{"key":"R31-6-20211004","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3945\/jn.111.149963","article-title":"Triglyceride-rich lipoprotein regulates apob48 receptor gene expression in human THP-1 monocytes and macrophages.","volume":"142","author":"Bermudez","year":"2012","journal-title":"J Nutr"},{"key":"R32-6-20211004","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/ejcn.2011.114","article-title":"Effect of three consecutive meals on the physicochemical properties of HDL and LDL in individuals with the metabolic syndrome and patients with type 2 diabetes.","volume":"65","author":"Scheffer","year":"2011","journal-title":"Eur J Clin Nutr"},{"key":"R33-6-20211004","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1194\/jlr.R700001-JLR200","article-title":"Remnant-like lipoprotein particles impair endothelial function: direct and indirect effects on nitric oxide synthase.","volume":"48","author":"Zheng","year":"2007","journal-title":"J Lipid Res"},{"key":"R34-6-20211004","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/ATVBAHA.107.159749","article-title":"Leukocyte activation by triglyceride-rich lipoproteins.","volume":"28","author":"Alipour","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R35-6-20211004","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/1474651411405259","article-title":"Oxidative DNA damage: antioxidant response in postprandial hyperglycaemia in type 2 diabetes mellitus.","volume":"11","author":"Al-Aubaidy","year":"2011","journal-title":"Br J Diab Vasc Dis"},{"key":"R36-6-20211004","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00394-010-0099-6","article-title":"Effects of antioxidants on postprandial oxidative stress and endothelial dysfunction in subjects with impaired glucose tolerance and type 2 diabetes.","volume":"49","author":"Neri","year":"2010","journal-title":"Eur J Nutr"},{"key":"R37-6-20211004","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3132\/dvdr.2007.026","article-title":"Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus.","volume":"4","author":"Hamilton","year":"2007","journal-title":"Diab Vasc Dis Res"},{"key":"R38-6-20211004","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.atherosclerosis.2012.01.029","article-title":"Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: Effect of fenofibrate treatment.","volume":"221","author":"Chan","year":"2012","journal-title":"Atherosclerosis"},{"key":"R40-6-20211004","first-page":"112","article-title":"Postprandial dysmetabolism: the missing link between diabetes and cardiovascular events Endocr P","volume":"14","author":"Bell","year":"2008","journal-title":"ract"},{"key":"R41-6-20211004","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2362.2009.02179.x","article-title":"Methods to assess impaired postprandial metabolism and the impact for early detection of cardiovascular disease risk.","volume":"39","author":"Su","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"R42-6-20211004","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2362.1999.00431.x","article-title":"Postprandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting state.","volume":"29","author":"Smith","year":"1999","journal-title":"Eur J Clin Invest"},{"key":"R43-6-20211004","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1194\/jlr.M600548-JLR200","article-title":"Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes.","volume":"48","author":"Hogue","year":"2007","journal-title":"J Lipid Res"},{"key":"R44-6-20211004","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cca.2011.09.013","article-title":"Establishment of chemiluminescence enzyme immunoassay for apolipoprotein B-48 and its clinical applications for evaluation of impaired chylomicron remnant metabolism.","volume":"413","author":"Hanada","year":"2012","journal-title":"Clinica Chimica Acta"},{"key":"R46-6-20211004","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1258\/acb.2011.011111","article-title":"Apolipoproteins: metabolic role and clinical biochemistry applications.","volume":"48","author":"Dominiczak","year":"2011","journal-title":"Ann Clin Biochem"},{"key":"R47-6-20211004","first-page":"13","article-title":"Comparison of different methods to investigate postprandial lipaemia.","volume":"67","author":"Van Oostrom","year":"2009","journal-title":"Neth J Med"},{"key":"R48-6-20211004","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/ijo.2008.73","article-title":"Effects of continuous versus accumulated activity patterns on postprandial triacylglycerol concentrations in obese men.","volume":"32","author":"Miyashita","year":"2008","journal-title":"Int J Obes"},{"key":"R49-6-20211004","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1152\/japplphysiol.90726.2008","article-title":"Effect of intensity of resistance exercise on postprandial lipemia.","volume":"106","author":"Singhal","year":"2009","journal-title":"J Appl Physiol"},{"key":"R50-6-20211004","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1590\/S1807-59322011000400003","article-title":"The influence of intense intermittent versus moderate continuous exercise on postprandial lipemia.","volume":"66","author":"Ferreira","year":"2011","journal-title":"Clinics"},{"key":"R51-6-20211004","first-page":"506","article-title":"Is the effect of prior exercise on postprandial lipaemia the same for a moderate-fat meal as it is for a high-fat meal Br J N","volume":"105","author":"Hurren","year":"2011","journal-title":"utr"},{"key":"R52-6-20211004","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1210\/jc.2010-0413","article-title":"The effect of a high-fat meal on postprandial arterial stiffness in men with obesity and type 2 diabetes.","volume":"95","author":"Phillips","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R53-6-20211004","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2337\/dc11-1593","article-title":"High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects.","volume":"35","author":"Harte","year":"2012","journal-title":"Diab Care"},{"key":"R55-6-20211004","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2174\/138945007780362809","article-title":"The effect of statins on postprandial lipemia.","volume":"8","author":"Kolovou","year":"2007","journal-title":"Curr Drug Targets"},{"key":"R56-6-20211004","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00129784-200808040-00004","article-title":"Therapeutic effects of fibrates in postprandial lipemia.","volume":"8","author":"Kolovou","year":"2008","journal-title":"Am J Cardiovasc Drugs"},{"key":"R57-6-20211004","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00380-010-0071-7","article-title":"Pitavastatin prevents postprandial endothelial dysfunction via reduction of the serum triglyceride level in obese male subjects.","volume":"26","author":"Nagashima","year":"2011","journal-title":"Heart Vessels"},{"key":"R58-6-20211004","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/01.CIR.0000027569.76671.A8","article-title":"Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short-and long-term simvastatin treatment.","volume":"106","author":"Ceriello","year":"2002","journal-title":"Circulation"},{"key":"R59-6-20211004","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/01.CIR.0000165070.46111.9F","article-title":"Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients.","volume":"111","author":"Ceriello","year":"2005","journal-title":"Circulation"},{"key":"R60-6-20211004","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2337\/dc07-0015","article-title":"Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome.","volume":"30","author":"Rosenson","year":"2007","journal-title":"Diab Care"},{"key":"R61-6-20211004","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2337\/diabetes.52.3.803","article-title":"Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.","volume":"52","author":"Watts","year":"2003","journal-title":"Diabetes"},{"key":"R62-6-20211004","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1194\/jlr.M300309-JLR200","article-title":"Effects of atorvastatin versus fenofibrate on apolipoprotein B-100 and apolipoprotein AI kinetics in mixed hyperlipidemia.","volume":"45","author":"Bilz","year":"2004","journal-title":"J Lipid Res"},{"key":"R63-6-20211004","first-page":"17","article-title":"Fenofibrate abrogates postprandial blood viscosity among hypertriglyceridemia subjects with the metabolic syndrome.","volume":"3","author":"Rosenson","year":"2009","journal-title":"Diab Metab Syndr Clin Res Rev"},{"key":"R64-6-20211004","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ajcn\/88.1.30","article-title":"Postprandial triglyceride responses to aerobic exercise and extended-release niacin.","volume":"88","author":"Plaisance","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"R65-6-20211004","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1093\/jn\/137.12.2635","article-title":"Weight loss, but not fish oil consumption, improves fasting and postprandial serum lipids, markers of endothelial function, and inflammatory signatures in moderately obese men.","volume":"137","author":"Plat","year":"2007","journal-title":"J Nutr"},{"key":"R66-6-20211004","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.plefa.2011.06.005","article-title":"Prescription omega-3-acid ethyl esters reduce fasting and postprandial triglycerides and modestly reduce pancreatic beta-cell response in subjects with primary hypertriglyceridemia.","volume":"85","author":"Maki","year":"2011","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"R67-6-20211004","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3945\/jn.109.120816","article-title":"A low-fat, high-complex carbohydrate diet supplemented with long-chain (n-3) fatty acids alters the postprandial lipoprotein profile in patients with metabolic syndrome.","volume":"140","author":"Jimenez-Gomez","year":"2010","journal-title":"J Nutr"},{"key":"R69-6-20211004","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2362.2009.02163.x","article-title":"Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia.","volume":"39","author":"Masuda","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"R70-6-20211004","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1194\/jlr.P800061-JLR200","article-title":"Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia.","volume":"50","author":"Tremblay","year":"2009","journal-title":"J Lipid Res"},{"key":"R71-6-20211004","doi-asserted-by":"crossref","first-page":"914","DOI":"10.5551\/jat.4929","article-title":"Molecular mechanisms of ezetimibe-induced attenuation of postprandial hypertriglyceridemia.","volume":"17","author":"Sandoval","year":"2010","journal-title":"J Atheroscl Thromb"},{"key":"R72-6-20211004","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.atherosclerosis.2011.04.019","article-title":"Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction.","volume":"217","author":"Yunoki","year":"2011","journal-title":"Atherosclerosis"},{"key":"R73-6-20211004","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000332436","article-title":"Effect of ezetimibe on remnant-like particle cholesterol in subjects with metabolic syndrome.","volume":"21","author":"Kotani","year":"2011","journal-title":"Med Princ Pract"},{"key":"R74-6-20211004","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.2337\/dc09-1765","article-title":"Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet.","volume":"33","author":"Chan","year":"2010","journal-title":"Diab Care"},{"key":"R75-6-20211004","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1074248411399762","article-title":"Effect of atorvastatin monotherapy and low-dose atorvastatinezetimibe combination on fasting and postprandial triglycerides in combined hyperlipedemia.","volume":"17","author":"Lee","year":"2011","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"R76-6-20211004","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.atherosclerosis.2008.04.035","article-title":"The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients.","volume":"202","author":"Hajer","year":"2009","journal-title":"Atherosclerosis"},{"key":"R77-6-20211004","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.atherosclerosis.2011.03.012","article-title":"Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes.","volume":"217","author":"Bozzetto","year":"2011","journal-title":"Atherosclerosis"},{"key":"R78-6-20211004","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.clinthera.2008.05.004","article-title":"Effect of exenatide on 24-h blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.","volume":"30","author":"Schwartz","year":"2008","journal-title":"Clin Ther"},{"key":"R79-6-20211004","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.atherosclerosis.2010.05.028","article-title":"Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus.","volume":"212","author":"Schwartz","year":"2010","journal-title":"Atherosclerosis"},{"key":"R80-6-20211004","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.2337\/dc09-1961","article-title":"Improvement of postprandial endothelial function after a single dose of exenatide in individuals with impaired glucose tolerance and recent-onset type 2 diabetes.","volume":"33","author":"Koska","year":"2010","journal-title":"Diab Care"},{"key":"R81-6-20211004","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12325-010-0110-x","article-title":"The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients.","volume":"28","author":"Flint","year":"2011","journal-title":"Adv Ther"},{"key":"R83-6-20211004","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1210\/jc.2003-030049","article-title":"Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes.","volume":"88","author":"Meier","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R84-6-20211004","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1463-1326.2011.01362.x","article-title":"Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes.","volume":"13","author":"Tremblay","year":"2011","journal-title":"Diab Obes Metab"},{"key":"R85-6-20211004","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1185\/03007995.2012.665046","article-title":"Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin.","volume":"28","author":"Barnett","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"R86-6-20211004","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00125-011-2447-3","article-title":"Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin andor pioglitazone: a randomised double-blind placebo-controlled study.","volume":"55","author":"Eliasson","year":"2012","journal-title":"Diabetologia"},{"key":"R87-6-20211004","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1463-1326.2010.01345.x","article-title":"Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control.","volume":"13","author":"Anagnostis","year":"2011","journal-title":"Diab Obes Metab"},{"key":"R88-6-20211004","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management.","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"},{"key":"R89-6-20211004","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a Scientific Statement From the American Heart Association.","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"R90-6-20211004","first-page":"1769","article-title":"ESCEAS Guidelines for the management of dyslipidaemias.","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J"},{"key":"R91-6-20211004","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc12-s011","article-title":"Standards of medical care in diabetes: 2012.","volume":"35","year":"2012","journal-title":"Diab Care"},{"key":"R92-6-20211004","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2337\/dc08-9018","article-title":"Lipoprotein management in patients with cardiometabolic risk.","volume":"31","author":"Brunzell","year":"2008","journal-title":"Diab Care"},{"key":"R93-6-20211004","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2174\/157016111795495549","article-title":"Assessment and clinical relevance of nonfasting and postprandial triglycerides: an expert panel statement.","volume":"9","author":"Kolovou","year":"2011","journal-title":"Curr Vasc Pharmacol"},{"key":"R94-6-20211004","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.","volume":"365","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00041433-201208000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T02:38:44Z","timestamp":1633315124000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041433-201208000-00006"}},"subtitle":["mechanistic and therapeutic aspects"],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":89,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0b013e328354c790","relation":{},"ISSN":["0957-9672"],"issn-type":[{"value":"0957-9672","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}